CAS: 1782970-28-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PTC-028 REF: AN-AG01FS6RCAS: 1782970-28-8 | 99% | 112.00 €~2,175.00 € | Thu 09 May 24 |
 | PTC-028 REF: TM-T16680CAS: 1782970-28-8 | 98.25% | 45.00 €~1,411.00 € | Thu 16 May 24 |
 | PTC 028 REF: 3D-BP168106CAS: 1782970-28-8 | Min. 95% | To inquire | Thu 20 Jun 24 |
Ref: AN-AG01FS6R
| 1mg | 112.00 € | |
| 2mg | 133.00 € | |
| 5mg | 194.00 € | |
| 10mg | 238.00 € | |
| 25mg | 590.00 € | |
| 50mg | 690.00 € | |
| 100mg | 991.00 € | |
| 500mg | 2,175.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
PTC-028
CAS:1782970-28-8
PTC-028 selectively suppresses cancer cells whereas normal cells remain unaffected. PTC-028 is an orally bioavailable …
Formula:
C19H12F5N5
Purity:
98.25%
Color and Shape:
Solid
Molecular weight:
405.32
Ref: TM-T16680
| 1mg | 45.00 € | |
| 2mg | 58.00 € | |
| 5mg | 96.00 € | |
| 10mg | 142.00 € | |
| 25mg | 276.00 € | |
| 50mg | 458.00 € | |
| 100mg | 674.00 € | |
| 500mg | 1,411.00 € | |
| 1ml*10 (DMSO) | 105.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
PTC 028
CAS:1782970-28-8
Lowers BMI-1 expression via post-translational modification; anti-cancer agent
Formula:
C19H12F5N5
Purity:
Min. 95%
Molecular weight:
405.32 g/mol
Ref: 3D-BP168106
| 10mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024
